The Faculty of Sexual and Reproductive Healthcare has issued updated advice on emergency contraception (EC).
The document aims to summarise the available evidence and provide recommendations for the use of copper-bearing intrauterine devices (Cu-IUD), levonorgestrel and, for the first time, ulipristal acetate (ellaOne®). It provides individual advice about each of the treatments and also specific advice regarding future contraception, drug interactions, side effects, multiple use in one cycle and advance provision.
Action: The advice and recommendations will be of value to any clinician who provides emergency contraception.
|« MeReC Bulletin - Making decisions better||Drug Safety Update - September 2011 »|